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Motivation
Outcome of a bloodstream infection/sepsis (BSI/S) is
defined in different ways in different research projects [1].
In this, BSI/S share the characteristics of other fields of
medicine; specific issues are related to diversity of causa-
tive agents, the clinical focus of infection, severity of
comorbid conditions, presence of indwelling devices, mul-
tiplicity of affected patient populations, and others [2].





• development/resolution of metastatic foci
• adverse events of treatment
• salvage of infected device
• relapse
• compliance
Therefore, the European Society of Clinical Microbiol-
ogy and Infectious Diseases working group on blood-
stream infections and sepsis (ESGBIS) is currently
designing a project for the development of a COS in BSI/S.
Objectives
1. generate a comprehensive long-list of all outcome
variables reported in recent randomised controlled
studies on BSI/S
2. refine the outcome long-list into a COS agreed by
key stakeholders
3. define the best measurement methods of proposed
COS
4. identify unresolved issues for further research
5. publish the proposed COS in the relevant scienti-
fic journals
6. build a COS database with standard fields easily
shared across studies
7. monitor uptake of the selected core outcomes in
future relevant publications
Methods
Overall timetable: 2 year from first meeting.
The ESGBIS group is composed by approximately 30
people with different backgrounds (infectious disease,
microbiology, intensive care medicine, epidemiology and
statistics). We will adopt a combination of methods: two
preparatory meetings, restricted and extended Delphi
rounds (via email exchanges), semi-structured interviews
with patients, systematic review of the literature, final
consensus conference (Figure 1).
Expected outputs
Publication of the systematic review and of the COS in
medical journals and development of a standard set of
database fields, to be included in eCRF of future studies.
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Figure 1 proposed structure of the BISON project
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